Risk-taking propensity as a predictor of induction onto naltrexone treatment for opioid dependence.
about
Motivational Deficits in Schizophrenia and the Representation of Expected ValueEffects of the NOP agonist SCH221510 on producing and attenuating reinforcing effects as measured by drug self-administration in rats.Neural correlates of adherence to extended-release naltrexone pharmacotherapy in heroin dependencePredictors of induction onto extended-release naltrexone among unemployed heroin-dependent adults.
P2860
Risk-taking propensity as a predictor of induction onto naltrexone treatment for opioid dependence.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Risk-taking propensity as a pr ...... eatment for opioid dependence.
@en
Risk-taking propensity as a pr ...... eatment for opioid dependence.
@nl
type
label
Risk-taking propensity as a pr ...... eatment for opioid dependence.
@en
Risk-taking propensity as a pr ...... eatment for opioid dependence.
@nl
prefLabel
Risk-taking propensity as a pr ...... eatment for opioid dependence.
@en
Risk-taking propensity as a pr ...... eatment for opioid dependence.
@nl
P2093
P2860
P356
P1476
Risk-taking propensity as a pr ...... eatment for opioid dependence.
@en
P2093
Annie Umbricht
C W Lejuez
George E Bigelow
Michael Fingerhood
S Geoffrey Severtson
Will M Aklin
P2860
P304
P356
10.4088/JCP.09M05807
P577
2012-08-01T00:00:00Z